A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(5 sites)

United States

Sarah Cannon Research Institute, Nashville, Tennessee

Australia

Greenslopes Private Hospital, Greenslopes, Queensland

Canada

Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Centre Hospitalier de l'Universite de Montreal, Montral, Quebec, Canada

United Kingdom

Royal Marsden Hospital, London